Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats

10.2337/dc10-S062

10.1007/s00394-015-0854-9

10.1111/j.1432-1033.1976.tb10827.x

10.2337/diabetes.54.1.1

10.2174/1573399810666140214093600

Chen, S, Jiang, H, Wu, X, and Fang, J (Array). Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm, 9340637.

10.1080/01635581.2012.725194

10.1097/00001813-199902000-00007

Friedewald, WT, Levy, RI, and Fredrickson, DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. <em>18</em>, 499-502.

10.3390/nu7105411

10.1016/0014-5793(72)80644-6

10.1016/S0168-8227(99)00067-4

10.1016/S0304-3835(01)00443-8

10.3109/13880209.2011.604677

10.2174/0929867033368547

10.1016/j.niox.2007.04.001

10.1042/cs0870021

10.1080/10408363.2017.1343274

10.1016/j.cbi.2008.11.008

10.1016/j.bbadis.2011.03.008

10.1002/jcb.23088

10.1007/s12011-014-9983-x

10.1089/jmf.2006.9.562

10.1016/j.taap.2006.01.003

10.1016/j.biopha.2016.12.044

10.1507/endocrj.K10E-399

10.1152/ajpendo.00487.2005

10.1111/j.1749-6632.2010.05844.x

10.1016/j.pharmthera.2009.11.001

10.1016/S1532-0456(03)00140-6

10.1038/35093198

Wang, GG, Lu, XH, Li, W, Zhao, X, and Zhang, C (Array). Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Alternat Med, 323171.

10.1046/j.1464-5491.2000.00259.x

10.2337/diacare.27.5.1047

Wilson, JF (2010). In clinic. Diabetic ketoacidosis. Ann Intern Med. <em>152</em>.

10.1007/s11892-007-0003-9

10.1186/s12986-016-0103-0

Zak, B, Epstein, E, and Baginski, ES (1977). Determination of liver microsomal glucose-6-phosphatase. Ann Clin Lab Sci. <em>7</em>, 169-177.

10.1111/j.1349-7006.2009.01215.x

10.1159/000452593

10.1021/pr3004826